BIOMAT Database Logo BIOMAT Database Logo

Uveitis after hepatitis B vaccination. 1987

M Fried, and D Conen, and M Conzelmann, and E Steinemann

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D014605 Uveitis Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed) Uveitides
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014761 Viral Hepatitis Vaccines Any vaccine raised against any virus or viral derivative that causes hepatitis. Hepatitis, Viral, Vaccines,Hepatitis Vaccines, Viral,Vaccines, Viral Hepatitis
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B

Related Publications

M Fried, and D Conen, and M Conzelmann, and E Steinemann
Seroconversion after hepatitis B vaccination.
August 1986, Annals of internal medicine,
M Fried, and D Conen, and M Conzelmann, and E Steinemann
Anaphylaxis after hepatitis B vaccination.
May 1995, Lancet (London, England),
M Fried, and D Conen, and M Conzelmann, and E Steinemann
Cryoglobulinemia after hepatitis B vaccination.
August 1996, The New England journal of medicine,
M Fried, and D Conen, and M Conzelmann, and E Steinemann
[Myasthenia after hepatitis B vaccination].
January 2003, Therapie,
M Fried, and D Conen, and M Conzelmann, and E Steinemann
Hepatitis B vaccination after liver transplantation.
July 2002, Hepatology (Baltimore, Md.),
M Fried, and D Conen, and M Conzelmann, and E Steinemann
[Localized scleroderma after hepatitis B vaccination].
January 2000, Presse medicale (Paris, France : 1983),
M Fried, and D Conen, and M Conzelmann, and E Steinemann
Acute hepatitis B infection after vaccination.
January 1995, Lancet (London, England),
M Fried, and D Conen, and M Conzelmann, and E Steinemann
Acute hepatitis B infection after vaccination.
January 1995, Lancet (London, England),
M Fried, and D Conen, and M Conzelmann, and E Steinemann
Acute hepatitis B infection after vaccination.
January 1995, Lancet (London, England),
M Fried, and D Conen, and M Conzelmann, and E Steinemann
Eosinophilia after intradermal hepatitis B vaccination.
October 1993, Lancet (London, England),
Copied contents to your clipboard!